hakia Issues Open Call to Librarians and Information Professionals: Help Us Guide Web Searchers to Credible... (t the Web Search University event inWash...)

hakia Issues Open Call to Librarians and Information Professionals: Help Us Guide Web Searchers to Credible Web Sites

Date:9/22/2008

t the Web Search University event in Washington DC.

"The campaign that hakia is starting is a great way to leverage the never-ending knowledge and information analysis skills of the information professional in building a Web database full of the web resources that are most useful, and most importantly, have the most credibility," said Gary Price, Editor, ResourceShelf.com. "This is a new chapter for library collection development. I hope this is only the beginning."

To learn more or suggest credible Web sites, please visit http://club.hakia.com/.

About hakia

hakia is a pioneer in the semantic search space and is currently in the late stages of developing technology with the potential to revolutionize the search industry. Founded in 2004, hakia is privately held and based in New York City. For more information about hakia, please visit http://www.hakia.com.

SOURCE hakia
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. hakia Boosts Health and Medical Search Capabilities with PubMed
2. College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues
3. PowerBar Issues Open Call for 2008-2009 PowerBar Team Elite(TM) Athlete Sponsorship Program
4. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
5. American Red Cross Issues Blood Supply Alert
6. OSHA Issues Draft Ergonomics Guidelines on Preventing Musculoskeletal Injuries in Shipyards
7. New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
8. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
9. Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
10. Dallas-Area Transplant Meeting Puts Spotlight on Key Issues
11. Elder Care Author Doctor Marion Launches Second National Tour to Raise Awareness About Aging & Elder Care Issues in America

Post Your Comments:

(Date:11/23/2009)...itationforFivePopulationHealthPrograms ,, LOVE...tionHealthImpactInstitute(PHII),anon-profit501(c)(...ofDirectorshasapprovedtheHealthcareTransparencyAcc...velopment.Nurtur(TM),alife,health,andwellnesscompa...ivetheH-TAPaccreditationsealforfiveofitsprograms. ...

(Date:11/23/2009).../PRNewswire/--ChristineHoehnehasjoined LocktonBene...brokerage.HoehnewillserveasanAccountExecutiveinLoc...ton,s Minneapolis office. ,, (Logo: http://www...., "WearethrilledtohaveChristinejoinourteam,"said...rvices."Shebroadensourabilitytoassistourmultinatio...

(Date:11/23/2009)...splants need longer-term support than most friends...se, according to a study of 160 patients published... Advanced Nursing . , Researchers surveyed 5...ear, together with 105 who had had surgery in the ...nt Center in Tennessee, USA. They wanted to see if...

(Date:11/23/2009)...1, has understandably captured the attention of pu...owever, an analysis from Children,s Hospital Bosto...ent (ED) during several recent flu seasons, shows ...SV) -- takes a substantially greater disease toll ...lthough the data come from the pre-H1N1 influenza ...

(Date:11/23/2009)...te Helps Organizations Meet HIPAA Compliance Requi...nd Eligibility, , (PRWEB)...leading provider of high-performance data integrat...y the launch of new products within its healthcare... other healthcare organizations meet industry stan...

Breaking Medicine News(10 mins):Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 2 Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 3 Health News:Lockton Benefit Group Expands International Benefit Team 2 Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 2 Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 3 Health News:Amid the flu epidemic, don't forget RSV in young children 2 Health News:Amid the flu epidemic, don't forget RSV in young children 3 Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 2 Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 3 Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 4

[0] Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM)[0] Lockton Benefit Group Expands International Benefit Team [0] Drug side effects a key factor in reduced quality of life for kidney transplant patients [0] Amid the flu epidemic, don't forget RSV in young children [0] BridgeGate Launches New Healthcare Integration and Interoperability Products

...igher quality diets also associated with higher in... (HealthDay News) -- People with higher levels of ...but pay more for selecting foods that are less ene...abetes, cardiovascular disease and some forms of c...

... Data Presented at American Heart Association ATVB...e Volume and Fewer New Plaque Lesions in Treated P...VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ) today ...d tomography (MDCT) scans before and after six mon...

... COSTA MESA, Calif., May 1 Oxygen Biotherapeutics...that the company has filed a Cosmetic Product Ingr...(TM) Gel, its new Oxycyte(R)-based cosmetic produc...ep closer to bringing our first product to market,...

... - Therapy is medically-necessary for thousands of...ue to cystic fibrosis or other conditions - , , ... today announced that the U.S. Food and Drug Admin...ibrosis (CF) or other conditions. CREON(R) is the ...

... Revenue Up 28%, EPS Up 77% Over Prior Year , , N...ced financial results for its first quarter ended ...9, revenue increased 28.2% to $49.9 million, compa...come of $3.2 million or $0.12 per fully diluted sh...

... Full-Year 2009 Guidance Range Increased to $2.70 ..., May 1, 2009 AMERIGROUP Corporation (NYSE: AGP...st quarter of 2009 increased 9.7% to $36.9 million...hlights include: , , , , Membership in...

More Educated Choose Healthier Foods, But Pay More VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel Video: CREON(R) (Pancrelipase) Delayed-Release Capsules First and Only Pancreatic Enzyme Product to Receive FDA Approval Under New Guidelines HMS Holdings Corp. Announces First Quarter 2009 Financial Results AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share

(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/--WoundManagementTechno...providerofspecialtymedicalproducts,announcedthatit...prehensivemanagementbusinessupdatetoillustratethed...9salesincreased33.5%to$102,926vs.Q32008salesof$77,...dto$3,327,892vs.Q32008shareholderequityof$(321,257...

(Date:11/23/2009)...v.23/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq...edbyitspartnerRoche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),w...intheongoingphase2btrialofRG7128,afirst-in-classnu...chronichepatitisCvirus(HCV)infection.Thedecisionwa...nitoringCommittee(DMC)ofallavailablesafetydatafrom...

(Date:11/23/2009)...ZER,Pa.,Nov.23/PRNewswire-FirstCall/--CeptionThera...y,andCephalon,Inc.(Nasdaq: CEPH )todayannouncedres...eslizumab)asatreatmentforpediatriceosinophilicesop...entintheco-primaryendpointsofchangesinesophagealeo...aindicatedthatpatientstreatedwithCINQUILshowedasta...

[0] Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update [0] Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C [0] Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis

...ansdel,Pharmaceuticals, Inc. (OTC Bulletin Board: ...and Drug Administration,s ("FDA") review of its Ph...e 3 clinical program for its,novel topical cream b...),Ketotransdel(TM). Transdel Pharmaceuticals is a ...lopment and commercialization of non-invasive,topi...

...ular Structures Needed for siRNA ...8 Silence Therapeutics plc,(AIM:SLN) Europe,s lea...ments on two recent journal articles: Nature(1) "S...ssion by siRNA via TLR3" Mark E.,Kleinman, et. al....,siRNA/Liposome Complexes in Mice is Sequence-Inde...

Other Medicine Technology:Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program 2 Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program 3 Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 2 Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 3 Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 4

Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach

SMZ-660

SMZ-645

SMZ-1500

Achroplan Wasser objectives

Medicine Products:

SMZ-660 SMZ-645 SMZ-1500 Achroplan Wasser objectives

hakia Issues Open Call to Librarians and Information Professionals: Help Us Guide Web Searchers to Credible...(t the Web Search University event inWash...),Health